Company Overview
RHYTHM PHARMACEUTICALS, INC.
RYTMRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
195M
2025 FY
Net Income
-197M
2025 FY
Shares Outstanding
65M
2025 FY
EPS
-3.11USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1649904
Exchange
Nasdaq
Location
US